PHARMACEUTICAL PRODUCT DEVELOPMENT INC Operating Cash Flow
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Operating Cash Flow of $150.74 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) operating activities for the quarter ending 2011-09-30 was $91.13M, a 90.33% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) operating activities for the quarter ending 2011-06-30 was $17.68M, a 70.26% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) operating activities for the quarter ending 2011-03-31 was $41.92M, a 32.40% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) operating activities for the quarter ending 2010-12-31 was $78.37M, a 32.37% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) operating activities for fiscal 2010 was $247.75M, a 2.08% decline from fiscal 2009.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) operating activities for fiscal 2009 was $253.00M, a 33.51% decline from fiscal 2008.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC net cash provided by (used in) operating activities for fiscal 2008 was $380.48M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2011-09-30 | $91.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $108.82M derived: sum of 2 quarters · filed 2011-11-02 | $150.74M 10-Q · filed 2011-11-02 | $229.12M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-06-30 | $17.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $59.61M 10-Q · filed 2011-08-04 | $137.98M derived: sum of 3 quarters · filed 2011-08-04 | $185.86M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-03-31 | $41.92M 10-Q · filed 2011-05-03 | $120.30M derived: sum of 2 quarters · filed 2011-05-03 | $168.18M derived: sum of 3 quarters · filed 2011-11-02 | $227.65M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-12-31 | $78.37M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $126.26M derived: sum of 2 quarters · filed 2011-11-02 | $185.73M derived: sum of 3 quarters · filed 2011-11-02 | $247.75M 10-K · filed 2011-02-25 |
| 2010-09-30 | $47.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $107.35M derived: sum of 2 quarters · filed 2011-11-02 | $169.37M 10-Q · filed 2011-11-02 | $285.26M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-06-30 | $59.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $121.49M 10-Q · filed 2011-08-04 | $237.38M derived: sum of 3 quarters · filed 2011-08-04 | $292.56M derived: sum of 4 quarters · filed 2011-08-04 |
| 2010-03-31 | $62.02M 10-Q · filed 2011-05-03 | $177.91M derived: sum of 2 quarters · filed 2011-05-03 | $233.09M derived: sum of 3 quarters · filed 2011-05-03 | |
| 2009-12-31 | $115.89M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $171.07M derived: sum of 2 quarters · filed 2011-02-25 | $253.00M 10-K · filed 2011-02-25 | |
| 2009-09-30 | $55.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $137.11M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $81.93M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | $380.48M 10-K · filed 2011-02-25 |